Cytek Biosciences, Inc. CTKB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.33% | -0.08% | 0.27% | -0.08% | -0.11% |
| Total Receivables | 18.48% | -9.17% | -21.70% | 16.95% | 8.83% |
| Inventory | 0.68% | 5.41% | 3.55% | -6.27% | 3.94% |
| Prepaid Expenses | -10.42% | -15.33% | -44.29% | 141.84% | -29.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -28.98% | 29.73% | 128.54% | -72.98% | 1.52% |
| Total Current Assets | 0.27% | -0.36% | -3.24% | 0.90% | 1.48% |
|
|
|||||
| Total Current Assets | 0.27% | -0.36% | -3.24% | 0.90% | 1.48% |
| Net Property, Plant & Equipment | -2.58% | 2.09% | 6.10% | 0.41% | -15.93% |
| Long-term Investments | 0.01% | 0.01% | -0.05% | -0.01% | -0.05% |
| Goodwill | 0.01% | 0.01% | -0.05% | -0.01% | -0.05% |
| Total Other Intangibles | -5.63% | -5.34% | -6.64% | -4.84% | -4.97% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.41% | 20.80% | -7.80% | -87.63% | 6.19% |
| Total Assets | -0.18% | -0.49% | -2.69% | -6.74% | 0.32% |
|
|
|||||
| Total Accounts Payable | -41.89% | 24.73% | 5.16% | -16.01% | 11.37% |
| Total Accrued Expenses | 15.72% | 17.77% | -14.25% | 16.12% | -1.99% |
| Short-term Debt | -12.19% | -12.68% | 77.51% | 849.33% | -57.14% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.94% | 9.14% | 1.84% | -65.47% | 36.73% |
| Total Finance Division Other Current Liabilities | 2.72% | -2.94% | 5.15% | 5.18% | -0.87% |
| Total Other Current Liabilities | 2.72% | -2.94% | 5.15% | 5.18% | -0.87% |
| Total Current Liabilities | 0.73% | 4.20% | 4.02% | 3.45% | 2.64% |
|
|
|||||
| Total Current Liabilities | 0.73% | 4.20% | 4.02% | 3.45% | 2.64% |
| Long-Term Debt | -59.76% | -36.27% | -26.48% | -19.85% | -17.19% |
| Short-term Debt | -12.19% | -12.68% | 77.51% | 849.33% | -57.14% |
| Capital Leases | -5.48% | 0.57% | -4.28% | 4.06% | -4.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.30% | 0.66% | -2.64% | 1.63% | -2.14% |
| Total Liabilities | -0.15% | 2.89% | 1.39% | 2.97% | 0.51% |
|
|
|||||
| Common Stock & APIC | 1.24% | 1.37% | 1.05% | 1.34% | 1.31% |
| Retained Earnings | -4.59% | -10.08% | -18.54% | -76.44% | -10.50% |
| Treasury Stock & Other | -3.65% | 15.62% | 5.71% | 172.96% | 2,260.53% |
| Total Common Equity | -0.19% | -1.74% | -4.12% | -9.73% | 0.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.19% | -1.74% | -4.12% | -9.73% | 0.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.19% | -1.74% | -4.12% | -9.73% | 0.27% |
|
|
|||||